Literature DB >> 22863800

Mucoadhesive tablets for controlled release of acyclovir.

Roberto Ruiz-Caro1, Manuel Gago-Guillan, Francisco Javier Otero-Espinar, María Dolores Veiga.   

Abstract

Mucoadhesive chitosan (CS) and/or hydroxypropyl-methylcellulose (HPMC) tablets for gastric drug delivery of acyclovir (ACV) have been developed in order to improve the ACV oral bioavailability. Swelling, bioadhesive and dissolution studies were carried out in two acidic media (pH 1.5 and 4) in order to determine the tablets behaviour in both fed and fasted states. All the designed tablets showed good mucoadhesive properties on gastric mucosa due to the presence of CS and/or HPMC. In vitro dissolution of ACV from tablets was influenced by the swelling behaviour of each polymer. All data release of the studied tablets fitted to Hopfenberg model, which describes drug release from tablets displaying heterogeneous erosion. HPMC and CS/HPMC tablets revealed a sustained release for 24 h, but a complete dissolution of the tablets was not produced at this time. On the contrary, tablets which contained only CS as polymer were able to release the total amount of ACV for 4 h, due to the CS imbibition and erosion processes in pH 1.5 medium. These results allowed us to conclude that CS is the excipient to be chosen to obtain gastroretentive formulations, due to its demonstrated gastric compatibility.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22863800     DOI: 10.1248/cpb.c12-00324

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  5 in total

1.  QbD-Enabled Development of Novel Stimuli-Responsive Gastroretentive Systems of Acyclovir for Improved Patient Compliance and Biopharmaceutical Performance.

Authors:  Bhupinder Singh; Anterpreet Kaur; Shashi Dhiman; Babita Garg; Rajneet Kaur Khurana; Sarwar Beg
Journal:  AAPS PharmSciTech       Date:  2015-08-04       Impact factor: 3.246

2.  The Influence of Chitosan on the Oral Bioavailability of Acyclovir--a Comparative Bioavailability Study in Humans.

Authors:  Marlies Kubbinga; Mai Anh Nguyen; Petra Staubach; Steven Teerenstra; Peter Langguth
Journal:  Pharm Res       Date:  2015-01-22       Impact factor: 4.200

3.  Chitosan and Kappa-Carrageenan Vaginal Acyclovir Formulations for Prevention of Genital Herpes. In Vitro and Ex Vivo Evaluation.

Authors:  María-Pilar Sánchez-Sánchez; Araceli Martín-Illana; Roberto Ruiz-Caro; Paulina Bermejo; María-José Abad; Rubén Carro; Luis-Miguel Bedoya; Aitana Tamayo; Juan Rubio; Anxo Fernández-Ferreiro; Francisco Otero-Espinar; María-Dolores Veiga
Journal:  Mar Drugs       Date:  2015-09-18       Impact factor: 5.118

Review 4.  Critical Review of Synthesis, Toxicology and Detection of Acyclovir.

Authors:  Yan-Ping Wei; Liang-Yuan Yao; Yi-Yong Wu; Xia Liu; Li-Hong Peng; Ya-Ling Tian; Jian-Hua Ding; Kang-Hua Li; Quan-Guo He
Journal:  Molecules       Date:  2021-10-29       Impact factor: 4.411

5.  A 5-fluorouracil-loaded floating gastroretentive hollow microsphere: development, pharmacokinetic in rabbits, and biodistribution in tumor-bearing mice.

Authors:  Yu Huang; Yumeng Wei; Hongru Yang; Chao Pi; Hao Liu; Yun Ye; Ling Zhao
Journal:  Drug Des Devel Ther       Date:  2016-03-03       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.